Aperiam Bio
Austin, US · Founded 2021 · Delaware corporation · 4 known investors
Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance. It applies this technology to develop technical reagents, shelf-stable enzymes for cosmetics, and pulmonary biologic therapeutics for its partners.
Founders & leadership
Aperiam Bio was founded in 2021 by Austin Cole.
AC
Austin ColeCEO & Founder
GC
Guillaume CottarelHead of Program
RD
Russell DurrettChief Business Officer
Investors · 4
Reported raises · per SEC filings
Form D private placements$7.7M disclosed across 2 rounds · 2022–2023
▶$4MraisedSep 2023 · 2 investors · BiotechnologyRule 506(b)
▶$4MraisedSep 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Austin ColeExecutive Officer, Director
- Amount sold
- $4M
- Minimum investment
- $100K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3.7MraisedMar 2022 · 3 investors · BiotechnologyRule 506(b)
▶$3.7MraisedMar 2022 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Austin ColeExecutive Officer, Director
- Amount sold
- $3.7M
- Minimum investment
- $100K
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Aperiam Bio do?
- Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance. It applies this technology to develop technical reagents, shelf-stable enzymes for cosmetics, and pulmonary biologic therapeutics for its partners.
- Who founded Aperiam Bio?
- Aperiam Bio was founded by Austin Cole in 2021.
- Who are Aperiam Bio's investors?
- Aperiam Bio's investors include Civilization Ventures Management, Llc, OMX Ventures, Axial VC, KdT Ventures.
- How much funding has Aperiam Bio raised?
- Aperiam Bio has disclosed $7.7M raised across 2 rounds.
- Where is Aperiam Bio headquartered?
- Aperiam Bio is headquartered in Austin, US.